“…In turn, bacteria have been shown to inhibit C. albicans filamentation by producing small signaling molecules, e.g., dodecanol and 3-oxo-C12-HSL from Pseudomonas aeruginosa, butyric acid from Lactobacillus rhamnosus, capric acid from Saccharomyces boulardii, cis-2-dodecenoic acid from Burkholderia cenocepacia, diffusible signal factor (DSF) from Xanthomonas campestris, and QSMs from Acinetobacter baumannii, Salmonella enterica Serovar Typhimurium, and Streptococcus mutans (Boon et al, 2008;Krasowska, Murzyn, Dyjankiewicz, Lukaszewicz, & Dziadkowiec, 2009;Murzyn, Krasowska, Stefanowicz, Dziadkowiec, & Lukaszewicz, 2010;Noverr & Huffnagle, 2004;Peleg et al, 2008;Tampakakis, Peleg, & Mylonakis, 2009;Wang et al, 2004). Lactobacillus spp., the most prevalent bacterial group in the female reproductive tract, as well as Enterococcus faecalis, a member of the GI-tract microbiota and an opportunistic pathogen, produce signaling molecules as metabolic byproducts (e.g., lactic acid, butyric acid), H 2 O 2 or organic acids that interfere with fungal adhesion, growth, adaptation or might influence the host immune response in an unfavorable way for C. albicans (Boris & Barbes, 2000;Braun, Hector, Kamark, Hart, & Cihlar, 1987;Cruz, Graham, Gagliano, Lorenz, & Garsin, 2013;Harriott & Noverr, 2011;Hoberg, Cihlar, & Calderone, 1983;Morales & Hogan, 2010;Noverr & Huffnagle, 2004;Strus et al, 2005;Wargo & Hogan, 2006). The necessary adaptations of C. albicans to these conditions are reflected in substantial changes in gene expression profiles when C. albicans is co-cultured with certain bacteria.…”